| Primary |
| Hypertension |
45.1% |
| Product Used For Unknown Indication |
38.8% |
| Blood Cholesterol Increased |
1.6% |
| Blood Pressure |
1.6% |
| Blood Pressure Increased |
1.1% |
| Headache |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Neurodermatitis |
1.1% |
| Antiviral Treatment |
0.8% |
| Drug Use For Unknown Indication |
0.8% |
| Gout |
0.8% |
| Heart Rate Irregular |
0.8% |
| Obesity |
0.8% |
| Psychotic Disorder |
0.8% |
| Vertebral Artery Dissection |
0.8% |
| Asthma |
0.5% |
| Blood Pressure Abnormal |
0.5% |
| Depression |
0.5% |
| Diabetes Mellitus |
0.5% |
| Drug Therapy Changed |
0.5% |
|
| Product Substitution Issue |
9.7% |
| Syncope |
9.7% |
| Suicidal Ideation |
8.8% |
| Renal Failure Acute |
7.1% |
| Visual Impairment |
7.1% |
| Tremor |
5.3% |
| Angioedema |
4.4% |
| Drug Ineffective |
4.4% |
| Palpitations |
4.4% |
| Pruritus |
4.4% |
| Urticaria |
4.4% |
| Cardiac Arrest |
3.5% |
| Headache |
3.5% |
| Renal Impairment |
3.5% |
| Sneezing |
3.5% |
| Tongue Blistering |
3.5% |
| Unresponsive To Stimuli |
3.5% |
| Vomiting |
3.5% |
| International Normalised Ratio Increased |
2.7% |
| Odynophagia |
2.7% |
|
| Secondary |
| Product Used For Unknown Indication |
34.3% |
| Hypertension |
29.3% |
| Drug Use For Unknown Indication |
7.0% |
| Diabetes Mellitus |
4.3% |
| Blood Pressure |
2.7% |
| Atrial Fibrillation |
2.6% |
| Blood Pressure Abnormal |
2.6% |
| Type 2 Diabetes Mellitus |
2.4% |
| Blood Cholesterol Increased |
2.2% |
| Blood Pressure Increased |
1.7% |
| Cardiac Disorder |
1.7% |
| Depression |
1.6% |
| Pain |
1.3% |
| Suicide Attempt |
1.2% |
| Rheumatoid Arthritis |
1.0% |
| Anticoagulant Therapy |
0.9% |
| Anxiety |
0.9% |
| Cardiovascular Disorder |
0.8% |
| Coronary Artery Disease |
0.8% |
| Prophylaxis |
0.8% |
|
| Renal Failure Acute |
14.8% |
| Completed Suicide |
12.5% |
| Vomiting |
12.5% |
| Throat Irritation |
6.3% |
| Orthostatic Hypotension |
4.7% |
| Syncope |
4.7% |
| Weight Decreased |
4.7% |
| Drug Ineffective |
3.9% |
| Toxicity To Various Agents |
3.9% |
| Abdominal Pain |
3.1% |
| Drug Hypersensitivity |
3.1% |
| Drug Toxicity |
3.1% |
| Malaise |
3.1% |
| Suspiciousness |
3.1% |
| Tremor |
3.1% |
| Urinary Tract Infection |
3.1% |
| Wrong Technique In Drug Usage Process |
3.1% |
| Death |
2.3% |
| Dizziness |
2.3% |
| Headache |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.9% |
| Hypertension |
22.3% |
| Rheumatoid Arthritis |
6.0% |
| Diabetes Mellitus |
5.0% |
| Drug Use For Unknown Indication |
3.6% |
| Pain |
3.1% |
| Blood Cholesterol Increased |
2.8% |
| Atrial Fibrillation |
2.8% |
| Depression |
2.6% |
| Blood Pressure |
2.2% |
| Type 2 Diabetes Mellitus |
2.1% |
| Cardiac Disorder |
2.1% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Asthma |
1.6% |
| Prophylaxis |
1.5% |
| Anxiety |
1.3% |
| Osteoporosis |
1.3% |
| Hypothyroidism |
1.3% |
| Psoriasis |
1.1% |
|
| Vomiting |
10.1% |
| Weight Decreased |
10.0% |
| Weight Increased |
7.6% |
| Drug Ineffective |
7.1% |
| Urinary Tract Infection |
5.7% |
| Pain In Extremity |
5.4% |
| Death |
4.6% |
| Nausea |
4.4% |
| Vision Blurred |
4.4% |
| Pain |
4.4% |
| Pruritus |
4.4% |
| Pneumonia |
3.9% |
| Rash |
3.8% |
| Tremor |
3.8% |
| Somnolence |
3.7% |
| Off Label Use |
3.6% |
| Wrong Technique In Drug Usage Process |
3.5% |
| Pyrexia |
3.4% |
| Visual Impairment |
3.2% |
| Renal Failure Acute |
3.1% |
|
| Interacting |
| Hypertension |
34.4% |
| Product Used For Unknown Indication |
12.5% |
| Cardiac Failure |
9.4% |
| Drug Use For Unknown Indication |
9.4% |
| Atrial Fibrillation |
6.3% |
| Blood Cholesterol Increased |
6.3% |
| Aortic Aneurysm |
3.1% |
| Diabetes Mellitus |
3.1% |
| Heart Rate Irregular |
3.1% |
| Hyperlipidaemia |
3.1% |
| Hypokalaemia |
3.1% |
| Nasal Congestion |
3.1% |
| Prophylaxis |
3.1% |
|
| Renal Failure Acute |
33.3% |
| Drug Interaction |
25.0% |
| Headache |
8.3% |
| Product Quality Issue |
8.3% |
| Transaminases Increased |
8.3% |
| Transient Ischaemic Attack |
8.3% |
| Visual Impairment |
8.3% |
|
